Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Hyperparathyroidism and bone disease after renal transplantation (CROSBI ID 168411)

Prilog u časopisu | pregledni rad (stručni)

Pavlović, Draško ; Orlić Lidija Hyperparathyroidism and bone disease after renal transplantation // Acta medica Croatica, 56 (2002), 41-43

Podaci o odgovornosti

Pavlović, Draško ; Orlić Lidija

engleski

Hyperparathyroidism and bone disease after renal transplantation

Metabolic bole disease is one of the most frequent complications of chronic renal failure. Numerous disorders leading to the metabolic bone disease can be reversed by successful renal transplantation. However, in some patients, in spite of satisfactory renal fuction, some disorder may persist for months after successful transplantation, e.g. increased parathyroid hormone secretion. Besides, drugs used in immunossuppresive therapy may cause metabolic bone disease or reduction bone mass. Therefore, significant loss of mass take place in the majority of patients during the first six months. Among drugs used in the prevention of bone disease after transplantation of solid organs the most important role have biphosphonates and vitamin D, i.e. calcitriol.

kidney transplantation; metabolic bone disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

56

2002.

41-43

objavljeno

1330-0164

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost